Benitec Biopharma
BNTC
$8.87
Share price
7.89%
Change (1 day)
4,334.30%
Change (1 year)
Benitec Biopharma (BNTC) - P/B ratio
P/B ratio as of May 2024 : 4.78
According to Benitec Biopharma
's latest financial reports the company has a price-to-book ratio of 4.78.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Benitec Biopharma - P/B ratio (from 2020 to 2019)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 0.5371 | 1.55% |
| 2022-12-31 | 0.5289 | -73.23% |
| 2021-12-31 | 1.98 | 118.64% |
| 2020-12-31 | 0.9037 | -99.61% |
| 2019-12-31 | 231 | -44.37% |
| 2018-12-31 | 415 | -55.86% |
| 2017-12-31 | 939 | 124.17% |
| 2016-12-31 | 419 | -31.37% |
| 2015-12-31 | 611 | |
| 2014-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | -6.34 | -232.67% | Bahamas |
 NRC Health
NRC | 17.1 | 256.59% | 🇺🇸 USA |